<DOC>
	<DOCNO>NCT00622180</DOCNO>
	<brief_summary>To assess 25-week period efficacy hand-foot narrow-band ultraviolet B light versus focal 308-nm light treatment induce return pigment vitiligo skin minigraft transplant back hand patient light brown black skin . Subject undergo treatment 13 week .</brief_summary>
	<brief_title>The Efficacy Hand NBUVB Versus Excilite Treatment Vitiligo After Minigrafting Dorsal Hands</brief_title>
	<detailed_description>Prospective investigator-blinded study involve 25 adult male female subject vitiligo back hand . Punch minigrafting perform hand take skin thigh and/or buttock . Light treatment administer start week one grafting . One hand receive narrow-band ultraviolet B light receive focal 308-nm light treatment . Light treatment administer 3 time per week 12 week . A long term follow-up visit complete week 25 . The investigator evaluate subject week 4 , 7 , 13 25 addition screen baseline evaluations/procedures .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<criteria>male female subject 18 year age old skin type IIIVI vitiligo dorsal hand history stable vitiligo ( new lesion 10 % enlargement exist lesion ) six month absence Kebner phenomenon ( new lesion appear trauma skin ) refractory topical steroid immunomodulators pregnant and/or breastfeed female history skin cancer history take photosensitizing medication history recent phototherapy ( light therapy ) topical medication within one month prior enrollment history organ transplantation history fail vitiligo skin transplantation history segmental vitiligo history 12 continuous light treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Vitiligo</keyword>
	<keyword>Light treatment vitiligo</keyword>
	<keyword>Excilite</keyword>
</DOC>